Studies have revealed that the expression of GLP-1 receptor is increased in neurons, GABAergic interneurons, microglia, astrocytes, and endothelial cells in the brain following the AIS (68, 7577)
Like any medication, GLP-1 receptor agonists come with potential side effects
Patients may avoid certain foods, depriving their teeth of essential nutrients
"States are also feeling substantial state budget pressure and we are doing our part to make sure patients, Medicaid enrollees all across the country can get access," Dan Tsai, the agency's top Medicaid official under the Biden administration, had told reporters
CagriSema is under FDA review with a decision expected by late 2026, and the RENEW program will give us a fuller picture of what cagrilintide can do as a standalone treatment
doi:10.22038/ijorl.2020.43663.2442